Establishment of a Novel Anti-CD44 Variant 10 Monoclonal Antibody C<sub>44</sub>Mab-18 for Immunohistochemical Analysis against Oral Squamous Cell Carcinomas.

Establishment of a Novel Anti-CD44 Variant 10 Monoclonal Antibody C₄₄Mab-18 for Immunohistochemical Analysis against Oral Squamous Cell Carcinomas.

Ishikawa, Kenichiro; Suzuki, Hiroyuki; Kaneko, Mika K; Kato, Yukinari.

Afiliação

Ishikawa K; Department of Molecular Pharmacology, Tohoku University Graduate School of Medicine, 2-1 Seiryo-machi, Aoba-ku, Sendai 980-8575, Japan.
Suzuki H; Department of Molecular Pharmacology, Tohoku University Graduate School of Medicine, 2-1 Seiryo-machi, Aoba-ku, Sendai 980-8575, Japan.
Kaneko MK; Department of Antibody Drug Development, Tohoku University Graduate School of Medicine, 2-1 Seiryo-machi, Aoba-ku, Sendai 980-8575, Japan.
Kato Y; Department of Molecular Pharmacology, Tohoku University Graduate School of Medicine, 2-1 Seiryo-machi, Aoba-ku, Sendai 980-8575, Japan.

Curr Issues Mol Biol ; 45(7): 5248-5262, 2023 Jun 21.

Article em En | MEDLINE | ID: mdl-37504249